Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-17
2007-04-17
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S338100
Reexamination Certificate
active
10012722
ABSTRACT:
This invention provides caspase inhibitors having the formula:wherein R1is CO2H, CH2CO2H, or esters, amides or isosteres thereof; R2and R3are each independently selected from hydrogen or an optionally substituted C1–C6aliphatic group; and R4and R5are each independently selected from hydrogen, an optionally substituted C1–C6aliphatic group, or R4and R5taken together with the ring to which they are attached form an optionally substituted bicyclic ring. The caspase inhibitors are useful for treating a number of diseases such as cancer, acute inflammatory and autoimmune disorders, ischemic diseases and certain neurodegenerative disorders.
REFERENCES:
patent: 5714484 (1998-02-01), Zimmerman et al.
patent: 5716929 (1998-02-01), Bemis et al.
patent: 2004/0192743 (2004-09-01), Mjalli et al.
patent: 95/35308 (1995-12-01), None
patent: WO 98/11129 (1998-03-01), None
Golec Julian M. C.
Kay David
Dixon Lisa A.
Kifle Bruck
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
LandOfFree
Imidazole and benzimidazole caspase inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole and benzimidazole caspase inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole and benzimidazole caspase inhibitors and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3759516